Ποια είναι η τιμή για Eckert & Ziegler SE (EUZ)

Η τιμή για Eckert & Ziegler SE (EUZ) είναι $16.26

Ποια είναι η κεφαλαιοποίηση αγοράς για Eckert & Ziegler SE (EUZ)

Η κεφαλαιοποίηση αγοράς για Eckert & Ziegler SE (EUZ) είναι $1.02B

Eckert & Ziegler SE (EUZ) Τιμή και Κεφαλαιοποίηση Αγοράς

Eckert & Ziegler SE manufactures and sells isotope technology components in Europe, North America, Asia, and internationally. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds based on iodine-125; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of choroidal melanomas; brain seed, HDR and brachytherapy; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynthesis equipment, quality-control equipment, consumables, therapeutic products and plant engineering, and other services. It offers standard and radiation sources for medical and industrial sectors; medical imaging and spect diagnostics, industrial analytical and instrument, high activity CS-137 and CO-60, and oil well logging sources; blood irradiators and environmental disposal source services; and bulk isotopes as well as calibration-related sources for radioisotopes. In addition, the company offers Tc-99m generators and supplies, trade in raw isotopes and other products, and services. It serves medical, scientific, and industrial applications. The company was formerly known as Eckert & Ziegler Strahlen- und Medizintechnik AG and changed its name to Eckert & Ziegler SE in March 2024. Eckert & Ziegler SE was founded in 1992 and is headquartered in Berlin, Germany.

Η τιμή για EUZ	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$84,118.89 $1.02B	NVDA	$5.264T	+517,166.74%
$75,128.43 $1.02B	AAPL	$4.701T	+461,882.29%
$66,753.11 $1.02B	GOOG	$4.177T	+410,380.51%
$61,003.72 $1.02B	MSFT	$3.817T	+375,026.19%
$45,805.31 $1.02B	AMZN	$2.866T	+281,567.55%

Η τιμή για EUZ

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$84,118.89 $1.02B